240 results
Page 4 of 12
424B3
1tp3hamx54vuywz4f
4 Feb 19
Prospectus supplement
5:52pm
S-4/A
cgcup6374u9
14 Jan 19
Registration of securities issued in business combination transactions (amended)
12:00am
S-4
tzvfmxzax gsxot
4 Jan 19
Registration of securities issued in business combination transactions
5:05pm
425
EX-2.1
32o9fx 0p15op7
8 Nov 18
Business combination disclosure
6:41am
425
kga3of8xy orfbf
8 Nov 18
Business combination disclosure
6:41am
8-K
EX-2.1
47wno cig
8 Nov 18
BioTime and ASTERIAS BIOTHERAPEUTICS enter into definitive merger agreement TO CREATE leading cell therapy company
6:41am
8-K
4opy g4w8qd3y0e
8 Nov 18
BioTime and ASTERIAS BIOTHERAPEUTICS enter into definitive merger agreement TO CREATE leading cell therapy company
6:41am
8-K
EX-99.1
1zmxfn62efafyt
8 Nov 18
BioTime ReportS Third Quarter 2018 Financial Results AND PROVIDES BUSINESS UPDATE
6:40am
425
EX-99.1
v45nkii9
8 Nov 18
Business combination disclosure
6:40am
8-K
EX-99.1
536he1wjr 2enka
2 Aug 18
BioTime Reports Second Quarter Results and Recent Corporate Accomplishments
4:13pm
8-K
EX-99.1
vtoqx3id5
10 May 18
BioTime Reports First Quarter Results and Recent Corporate Accomplishments
4:24pm
8-K
EX-1.1
fep3b xo6hh
13 Oct 17
Entry into a Material Definitive Agreement
12:00am